Interferon-gamma (IFNy) in macrophage activation syndrome (MAS) associated with systemic juvenile idiopathic arthritis (sJIA). High levels in patients and a role in a murine mas model

Eitemau Tebyg

• High levels of interferon-gamma (IFNγ) in macrophage activation syndrome (MAS) and CXCL9 levels as a biomarker for IFNγ production in MAS
  gan: Bracaglia, C, et al.
  Cyhoeddwyd: (2015)
• S100A12 as diagnostic tool in the differential diagnosis of sJIA associated MAS vs. hereditary or acquired HLH
  gan: Holzinger, D, et al.
  Cyhoeddwyd: (2015)
• Distinct gene expression signatures characterize strong clinical responders vs non-responders to Canakinumab in children with sJIA
  gan: Verweyen, Emely L, et al.
  Cyhoeddwyd: (2021)
• Mutations of familial hemophagocytic lymphohistiocytosis (FHL) related genes and abnormalities of cytotoxicity function tests in patients with macrophage activation syndrome (MAS) occurring in systemic juvenile idiopathic arthritis (sJIA)
  gan: Bracaglia, Claudia, et al.
  Cyhoeddwyd: (2014)
• IL-18 production upon s100 stimulation is reduced in active sJIA patients compared to sJIA patients in remission and healthy controls
  gan: Haar, Nienke Ter, et al.
  Cyhoeddwyd: (2014)